UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

The New England journal of medicine, 2023-09, Vol.389 (13), p.1167-1179

2023

Link zum Volltext

Verfügbarkeit prüfen

‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey

The American journal of medicine, 2014-06, Vol.127 (6), p.519-529.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging

International journal of cardiology. Heart & vasculature, 2018-12, Vol.21, p.11-15

2018

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Europace (London, England), 2018-05, Vol.20 (5), p.731-732an

2018

Link zum Volltext

Verfügbarkeit prüfen

Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN‐AF survey

International journal of clinical practice (Esher), 2021-06, Vol.75 (6), p.e14080-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

Clinical research in cardiology, 2022-01, Vol.111 (1), p.70-84

2022

Link zum Volltext

Verfügbarkeit prüfen

Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still's disease. Does terminology matter?

Romanian journal of internal medicine = Revue roumaine de medecine interne, 2022-03, Vol.60 (1), p.3

2022

Link zum Volltext

Verfügbarkeit prüfen

The neutrophil to lymphocyte ratio in heart failure: a comprehensive review

Romanian journal of internal medicine = Revue roumaine de medecine interne, 2019-12, Vol.57 (4), p.296

2019

Link zum Volltext

Verfügbarkeit prüfen

Stroke prevention in elderly patients with non‐valvular atrial fibrillation in the BALKAN‐AF survey

European journal of clinical investigation, 2020-03, Vol.50 (3), p.e13200-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden

International journal of cardiology. Heart & vasculature, 2020-08, Vol.29, p.100610-100610, Article 100610

Dan, Gheorghe-Andrei

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.17-25

2021

Link zum Volltext

Verfügbarkeit prüfen

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation

European journal of heart failure, 2015-06, Vol.17 (6), p.570-582

2015

Link zum Volltext

Verfügbarkeit prüfen

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Europace (London, England), 2017-06, Vol.19 (6), p.891-911

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmic Drugs

1st ed. 2020., 2020

Link zum Volltext

Verfügbarkeit prüfen

Determinants of Prolonged Length of Hospital Stay of Patients with Atrial Fibrillation

Journal of clinical medicine, 2021-08, Vol.10 (16), p.3715

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Impact of Severe Atrial Functional Tricuspid Regurgitation in Atrial Fibrillation Patients

Journal of clinical medicine, 2022-12, Vol.11 (23), p.7145

2022

Link zum Volltext

Verfügbarkeit prüfen

The wearable cardioverter-defibrillator: current technology and evolving indications

Europace (London, England), 2017-03, Vol.19 (3), p.335-345

2017

Link zum Volltext

Verfügbarkeit prüfen

Polypill revisited – Unity in diversity

International journal of cardiology. Heart & vasculature, 2020-08, Vol.29, p.100607-100607, Article 100607

2020

Link zum Volltext

Verfügbarkeit prüfen

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy

European heart journal supplements, 2022-06, Vol.24 (Suppl D), p.D1-D2

Dan, Gheorghe-Andrei

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

Journal of clinical medicine, 2023-01, Vol.12 (3), p.768

2023

Link zum Volltext

Verfügbarkeit prüfen

Implications of geographical variation on clinical outcomes of cardiovascular trials

The American heart journal, 2012-09, Vol.164 (3), p.303-312

2012

Link zum Volltext

Verfügbarkeit prüfen

The net clinical benefit of the antithrombotic protection in prosthetic mechanical valves: Changing the paradigm

International journal of cardiology, 2018-09, Vol.267, p.77-78

Dan, Gheorghe-Andrei

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey

Journal of arrhythmia, 2020-10, Vol.36 (5), p.863-873

2020

Link zum Volltext

Verfügbarkeit prüfen

Sex Differences in Cardiovascular Management: A Call for Better Acknowledgment-Part 1 Pharmacological Differences in Women and Men; How Relevant Are They?

American journal of therapeutics, 2024-05, Vol.31 (3), p.e237

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)

Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN‐AF survey

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still's disease. Does terminology matter?

The neutrophil to lymphocyte ratio in heart failure: a comprehensive review

Stroke prevention in elderly patients with non‐valvular atrial fibrillation in the BALKAN‐AF survey

Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation

Antiarrhythmic Drugs

Determinants of Prolonged Length of Hospital Stay of Patients with Atrial Fibrillation

Prognostic Impact of Severe Atrial Functional Tricuspid Regurgitation in Atrial Fibrillation Patients

The wearable cardioverter-defibrillator: current technology and evolving indications

Polypill revisited – Unity in diversity

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy

Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

Implications of geographical variation on clinical outcomes of cardiovascular trials

The net clinical benefit of the antithrombotic protection in prosthetic mechanical valves: Changing the paradigm

Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey

Sex Differences in Cardiovascular Management: A Call for Better Acknowledgment-Part 1 Pharmacological Differences in Women and Men; How Relevant Are They?

Suchergebnisse filtern